Autofluorescence-free, imaging-guided precision therapy for rheumatoid arthritis
Rheumatoid arthritis (RA), also known as \”immortal carcinoma,\” is a chronic autoimmune inflammatory condition. The application and development of a high-sensitivity RA theranostics can help accurately monitor RA’s progression and achieve efficient treatment.
In a study published in Advanced Science, a research group led by Prof. Zhang Yun from Fujian Institute of Research on the Structure of Matter of the Chinese Academy of Sciences developed a dual-triggered theranostics nanoprobe based on persistent luminescence nanoparticles (PLNPs) for RA autofluorescence-free imaging-guided precise treatment and therapeutic evaluation.
Researchers first prepared Zn1.3 Ga1.4 Sn0.3O4:0.5%Cr3+ and 0.3%Y3+ PLNPs that emit near-infrared light (NIR), using a simple mesoporous template method.
Source:
https://phys.org/news/2023-02-autofluorescence-free-imaging-guided-precision-therapy-rheumatoid.html
